Nanobiotechnology as an emerging approach to combat malaria: A systematic review.


Journal

Nanomedicine : nanotechnology, biology, and medicine
ISSN: 1549-9642
Titre abrégé: Nanomedicine
Pays: United States
ID NLM: 101233142

Informations de publication

Date de publication:
06 2019
Historique:
received: 10 09 2018
revised: 01 02 2019
accepted: 15 02 2019
pubmed: 25 3 2019
medline: 4 12 2019
entrez: 25 3 2019
Statut: ppublish

Résumé

Mosquitoes (Diptera; Culicidae) present a major threat to millions of people and animals worldwide, as they act as vectors for various pathogens, especially parasites and viruses. Resistance to insecticides, such as organophosphates and microbial control agents, and insufficient adherence to application guidelines are common reasons for insecticide treatment failure. Therefore, there is an urgent need for exploration of safer, cheaper, and more effective agents, with novel modes of action, to improve mosquito control. Biosynthesized nanoparticles (NPs) have recently been considered as a potential approach for combating vectors of malaria and also as a treatment for malaria. Here, we present current knowledge about the characterization and effectiveness of biogenic NPs against major vectors of malaria, including avian malaria (which may also provide useful insights on vectors of human malaria). This article is the first systematic review of the effects of biosynthesized nanoparticles on both malaria parasites (Plasmodium spp.) and relevant vectors.

Identifiants

pubmed: 30904586
pii: S1549-9634(19)30048-6
doi: 10.1016/j.nano.2019.02.017
pii:
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

221-233

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Hamed Barabadi (H)

Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Zahra Alizadeh (Z)

Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.

Mohammad Taghi Rahimi (MT)

School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran.

Aleksandra Barac (A)

Clinic for Infectious and Tropic Diseases, Clinical Centre of Serbia, Belgrade, Serbia.

Alberto Enrico Maraolo (AE)

Department of Clinical Medicine and Surgery, University of Naples "Federico II", Naples, Italy.

Lucy J Robertson (LJ)

Department of Food Safety and Infection Biology, Faculty of Veterinary Medicine, Norwegian University of Life Sciences, Oslo, Norway.

Ali Masjedi (A)

Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.

Firooz Shahrivar (F)

Department of Parasitology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

Ehsan Ahmadpour (E)

Infectious and Tropical Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: ehsanahmadpour@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH